Ads by Google
New UCLA research suggests that for seniors age 70 and older, socioeconomic status does not play a major role in the brain's continued ability to function.
Most Americans would like to live well into their 80s according to a new national study released by the Pew Research Center.
A drug known to suppress the immune system, and possibly inhibit cancer and other destructive aging processes, is the new frontrunner in federally supported anti-aging studies.
In the study, mice fed the drug rapamycin, even starting in late middle age, had their lifespan extended by 9 to 14 percent. The results appear online and will be published in the journal Nature.
Older adults' predicted annual medical care expenditures can be reduced significantly through the use of cognitive training, according to a research team led by Fredric Wolinsky, Ph.D., who holds the John W. Colloton Chair in Health Management and Policy in the University of Iowa College of Public Health.
The team evaluated the effects of three cognitive training interventions (memory, reasoning, or speed of processing) on changes in predicted medical care expenditures. Five-year follow-up data were available for 1,804 of the 2,802 original study participants.
Researchers have found that rapamycin, a compound that has antifungal and antibiotic properties, found in the soil at Easter Island, extended the lifespan of mice who were fed the potential anti-aging chemical. Rapamycin could become a genuine anti-aging treatment that could promote quality of life with aging.
U.S. seniors performed significantly better than their counterparts in England on standard tests of memory and cognitive function, according to a new study.
The study is the first known international comparison of cognitive function in nationally representative samples of older adults in the United States and England. The report is published in the June 25 peer-reviewed journal BMC Geriatrics.